Thermo Fisher (TMO) Stock Forecast & Price Target

Compare

4,806 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TMO Analyst Ratings

Strong Buy

16 Buy

3 Hold

0 Sell

Based on 19 analysts giving stock ratings to

Thermo

Fisher

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TMO Stock 12 Month Forecast

Average Price Target

$546.72

▲(31.33%Upside)

Based on 19 Wall Street analysts offering 12 month price targets for Thermo Fisher in the last 3 months. The average price target is $546.72 with a high forecast of $620.00 and a low forecast of $450.00. The average price target represents a 31.33% change from the last price of $416.31.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"395":"$395","508":"$508","621":"$621","451.5":"$451.5","564.5":"$564.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":620,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$620.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":546.72,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$546.72</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":450,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$450.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[395,451.5,508,564.5,621],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,421.47,436.7415384615385,452.01307692307694,467.2846153846154,482.55615384615385,497.8276923076923,513.0992307692308,528.3707692307693,543.6423076923077,558.9138461538462,574.1853846153846,589.4569230769231,604.7284615384615,{"y":620,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,421.47,431.1046153846154,440.7392307692308,450.37384615384616,460.0084615384616,469.64307692307693,479.27769230769235,488.9123076923077,498.5469230769231,508.1815384615385,517.8161538461538,527.4507692307693,537.0853846153847,{"y":546.72,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,421.47,423.6646153846154,425.8592307692308,428.05384615384617,430.2484615384616,432.44307692307694,434.6376923076923,436.8323076923077,439.0269230769231,441.22153846153844,443.41615384615386,445.6107692307692,447.80538461538464,{"y":450,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":539.96,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":619.75,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":613.07,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":611.33,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":556.46,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":528.56,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":519.25,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":596.63,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":527.96,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":482.47,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":419.46,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":396.06,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":421.47,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$620.00

Average Price Target$546.72

Lowest Price Target$450.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$470

Buy

12.90%

Upside

Reiterated

07/16/25

Thermo Fisher's overall stock score reflects strong financial performance and strategic resilience in the face of macroeconomic challenges, as highlighted in the earnings call. Technical indicators suggest a stable outlook, while valuation metrics indicate fair pricing. The company's focus on innovation and acquisitions positions it for sustained growth despite current pressures.

Daniel BrennanTD Cowen

TD Cowen

$570→$550

Buy

32.11%

Upside

Reiterated

07/16/25

Thermo Fisher (TMO) Receives a Buy from TD Cowen

Brandon CouillardWells Fargo

Wells Fargo

$570

Buy

36.92%

Upside

Reiterated

07/11/25

Thermo Fisher (TMO) Gets a Buy from Wells Fargo

Sung Ji NamScotiabank

Scotiabank

$605→$590

Hold

41.72%

Upside

Downgraded

07/11/25

Thermo Fisher upgraded to Outperform from Sector Perform at ScotiabankThermo Fisher upgraded to Outperform from Sector Perform at Scotiabank

Dan LeonardUBS

UBS

$500→$460

Hold

10.49%

Upside

Downgraded

07/09/25

Thermo Fisher downgraded to Neutral from Buy at UBSThermo Fisher downgraded to Neutral from Buy at UBS

Vijay KumarEvercore ISI

Evercore ISI

$500→$480

Buy

15.30%

Upside

Reiterated

07/08/25

Evercore ISI Keeps Their Buy Rating on Thermo Fisher (TMO)

Eve BursteinBernstein

Bernstein

$560

Buy

34.52%

Upside

Reiterated

07/07/25

We maintain our Outperform ratings on TMO, WAT, and PACB.

Conor McNamaraRBC Capital

RBC Capital

$569→$572

Buy

37.40%

Upside

Reiterated

07/01/25

RBC Capital Sticks to Its Buy Rating for Thermo Fisher (TMO)

Michael RyskinBank of America Securities

Bank of America Securities

$545

Buy

30.91%

Upside

Reiterated

06/26/25

Analysts Are Bullish on These Healthcare Stocks: Rhythm Pharmaceuticals (RYTM), Thermo Fisher (TMO)

Luke SergottBarclays

Barclays

$475→$450

Hold

8.09%

Upside

Reiterated

06/24/25

Thermo Fisher price target lowered to $450 from $475 at BarclaysThermo Fisher price target lowered to $450 from $475 at Barclays

Puneet SoudaLeerink Partners

Leerink Partners

$600→$500

Buy

20.10%

Upside

Reiterated

06/23/25

Leerink Partners Sticks to Their Buy Rating for Thermo Fisher (TMO)

David ToungArgus Research

Argus Research

―

Buy

―

Reiterated

04/28/25

Analysts Are Bullish on Top Healthcare Stocks: NeoGenomics (NEO), Thermo Fisher (TMO)

Jill WuCMB International Securities

CMB International Securities

$690→$526

Buy

26.35%

Upside

Reiterated

04/25/25

Thermo Fisher's Strategic Resilience Amid Macroeconomic Challenges: A Buy Recommendation

Catherine Ramsey SchulteRobert W. Baird

Robert W. Baird

$603→$573

Buy

37.64%

Upside

Reiterated

04/24/25

Thermo Fisher price target lowered to $573 from $603 at BairdThermo Fisher price target lowered to $573 from $603 at Baird

Tejas SavantMorgan Stanley

Morgan Stanley

$678→$550

Buy

32.11%

Upside

Reiterated

04/24/25

Analysts Offer Insights on Healthcare Companies: Thermo Fisher (NYSE: TMO), Edwards Lifesciences (NYSE: EW) and Viking Therapeutics (NASDAQ: VKTX)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$470

Buy

12.90%

Upside

Reiterated

07/16/25

Daniel BrennanTD Cowen

TD Cowen

$570→$550

Buy

32.11%

Upside

Reiterated

07/16/25

Thermo Fisher (TMO) Receives a Buy from TD Cowen

Brandon CouillardWells Fargo

Wells Fargo

$570

Buy

36.92%

Upside

Reiterated

07/11/25

Thermo Fisher (TMO) Gets a Buy from Wells Fargo

Sung Ji NamScotiabank

Scotiabank

$605→$590

Hold

41.72%

Upside

Downgraded

07/11/25

Thermo Fisher upgraded to Outperform from Sector Perform at ScotiabankThermo Fisher upgraded to Outperform from Sector Perform at Scotiabank

Dan LeonardUBS

UBS

$500→$460

Hold

10.49%

Upside

Downgraded

07/09/25

Thermo Fisher downgraded to Neutral from Buy at UBSThermo Fisher downgraded to Neutral from Buy at UBS

Vijay KumarEvercore ISI

Evercore ISI

$500→$480

Buy

15.30%

Upside

Reiterated

07/08/25

Evercore ISI Keeps Their Buy Rating on Thermo Fisher (TMO)

Eve BursteinBernstein

Bernstein

$560

Buy

34.52%

Upside

Reiterated

07/07/25

We maintain our Outperform ratings on TMO, WAT, and PACB.

Conor McNamaraRBC Capital

RBC Capital

$569→$572

Buy

37.40%

Upside

Reiterated

07/01/25

RBC Capital Sticks to Its Buy Rating for Thermo Fisher (TMO)

Michael RyskinBank of America Securities

Bank of America Securities

$545

Buy

30.91%

Upside

Reiterated

06/26/25

Analysts Are Bullish on These Healthcare Stocks: Rhythm Pharmaceuticals (RYTM), Thermo Fisher (TMO)

Luke SergottBarclays

Barclays

$475→$450

Hold

8.09%

Upside

Reiterated

06/24/25

Thermo Fisher price target lowered to $450 from $475 at BarclaysThermo Fisher price target lowered to $450 from $475 at Barclays

Puneet SoudaLeerink Partners

Leerink Partners

$600→$500

Buy

20.10%

Upside

Reiterated

06/23/25

Leerink Partners Sticks to Their Buy Rating for Thermo Fisher (TMO)

David ToungArgus Research

Argus Research

―

Buy

―

Reiterated

04/28/25

Analysts Are Bullish on Top Healthcare Stocks: NeoGenomics (NEO), Thermo Fisher (TMO)

Jill WuCMB International Securities

CMB International Securities

$690→$526

Buy

26.35%

Upside

Reiterated

04/25/25

Thermo Fisher's Strategic Resilience Amid Macroeconomic Challenges: A Buy Recommendation

Catherine Ramsey SchulteRobert W. Baird

Robert W. Baird

$603→$573

Buy

37.64%

Upside

Reiterated

04/24/25

Thermo Fisher price target lowered to $573 from $603 at BairdThermo Fisher price target lowered to $573 from $603 at Baird

Tejas SavantMorgan Stanley

Morgan Stanley

$678→$550

Buy

32.11%

Upside

Reiterated

04/24/25

Analysts Offer Insights on Healthcare Companies: Thermo Fisher (NYSE: TMO), Edwards Lifesciences (NYSE: EW) and Viking Therapeutics (NASDAQ: VKTX)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Thermo Fisher

1 Month

xxx

Success Rate

15/26 ratings generated profit

Average Return

+0.13%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 57.69% of your transactions generating a profit, with an average return of +0.13% per trade.

3 Months

xxx

Success Rate

29/42 ratings generated profit

Average Return

+3.74%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 69.05% of your transactions generating a profit, with an average return of +3.74% per trade.

1 Year

Catherine Ramsey SchulteRobert W. Baird

Success Rate

26/42 ratings generated profit

Average Return

+11.32%

reiterated a buy rating 3 months ago

Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 61.90% of your transactions generating a profit, with an average return of +11.32% per trade.

2 Years

xxx

Success Rate

26/42 ratings generated profit

Average Return

+21.85%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 61.90% of your transactions generating a profit, with an average return of +21.85% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TMO Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TMO has received 16 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. TMO average Analyst price target in the past 3 months is 546.72.

Each month's total comprises the sum of three months' worth of ratings.

TMO Financial Forecast

TMO Earnings Forecast

Next quarter’s earnings estimate for TMO is $5.23 with a range of $5.19 to $5.29. The previous quarter’s EPS was $5.15. TMO beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 42.22% of the time in the same period. In the last calendar year TMO has Preformed in-line its overall industry.

TMO Sales Forecast

Next quarter’s sales forecast for TMO is $10.68B with a range of $10.49B to $10.76B. The previous quarter’s sales results were $10.36B. TMO beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 56.06% of the time in the same period. In the last calendar year TMO has Preformed in-line its overall industry.

TMO Stock Forecast FAQ

What is TMO’s average 12-month price target, according to analysts?

Based on analyst ratings, Thermo Fisher Scientific’s 12-month average price target is 546.72.

What is TMO’s upside potential, based on the analysts’ average price target?

Thermo Fisher Scientific has 31.33% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TMO a Buy, Sell or Hold?

Thermo Fisher Scientific has a consensus rating of Strong Buy which is based on 16 buy ratings, 3 hold ratings and 0 sell ratings.

What is Thermo Fisher Scientific’s price target?

The average price target for Thermo Fisher Scientific is 546.72. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $620.00 ,the lowest forecast is $450.00. The average price target represents 31.33% Increase from the current price of $416.31.

What do analysts say about Thermo Fisher Scientific?

Thermo Fisher Scientific’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.

How can I buy shares of TMO?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Thermo Fisher (TMO) Stock Forecast & Price Target

TMO Analyst Ratings

TMO Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Thermo Fisher

TMO Analyst Recommendation Trends

TMO Financial Forecast

TMO Earnings Forecast

TMO Sales Forecast

TMO Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts